Bajolo, Baby Boy .
HRN: 23-24-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2024
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
12/16/2024
12/22/2024
PO
2ml
BID
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes